Alzheimer's drug TRx0237 put to the test in large trial
Disease control
Completed
This study tested whether a drug called TRx0237 can help people with Alzheimer's disease. About 600 participants took either a low dose, a higher dose, or a placebo for 12 months, followed by a year where everyone could get the drug. The goal was to see if the drug slows memory l…
Phase: PHASE3 • Sponsor: TauRx Therapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 13:28 UTC